Osama Hamdy
Endocrinology, Diabetes & Metabolism · Boston, MANPI 1902841596
Payments from drug & device makers
Across 1,191 payments — averaging $896.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$457K
- Eli Lilly$439K
- Sanofi-aventis U.S. LLC$80K
- Mannkind Corporation$55K
- AstraZeneca$10K
- Upjohn US 1 LLC$6K
- plus $21K from 8 others
Across 4 payments — averaging $8949.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$36K
- Novo Nordisk$48
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 1,124 | $457,094 |
| Eli Lilly | 22 | $439,237 |
| Sanofi-aventis U.S. LLC | 17 | $79,670 |
| Mannkind Corporation | 5 | $54,952 |
| AstraZeneca | 1 | $9,765 |
| Upjohn US 1 LLC | 1 | $6,400 |
| Takeda | 1 | $5,000 |
| Gilead | 10 | $3,936 |
| Novo Nordisk | 3 | $3,915 |
| BD | 1 | $3,750 |
| Insulet Corporation | 2 | $2,099 |
| Mylan Inc. | 1 | $2,000 |
| Abbott | 2 | $56 |
| Inspire Medical Systems, Inc. | 1 | $15 |
How this compares
$1,067,889 in reported general payments places this provider in the 95th percentile of 360 endocrinology, diabetes & metabolism providers in Massachusetts.
See all endocrinology, diabetes & metabolism providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Boston
- David NathanBoston$9M
- Vanita ArodaBoston$4.2M
- George KingBoston$3.7M
- Karen MillerBoston$2.9M
- Steven GrinspoonBoston$2.7M
- Jason GagliaBoston$2.5M
- Elaine YuBoston$1.3M
- Steven RussellBoston$1.1M
- Christos MantzorosBoston$983K
- Benjamin LederBoston$912K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.